About
History
Director
Organization
Research
All Faculty
Neuroscience
Cardiovascular & Metabolic Diseases
Infectious Disease & Immunology
Cancer
Resource
Administrative
Core facilities
Funding
Events
News
Seminars
Conferences
Careers
Jobs
Education Programs
Links
WebMail
Intranet
Publications
Epidemic Prevention
Links
Online Booking
中文
Dr. Jou, Yuh-Shan
Distinguished Research Fellow
27899062,26523525(Lab) (Lab) (Room No: N606)
26523521(O)
27827654 (Fax)
Specialty:
Cancer Genomics
Molecular Cancer Biology
Bioinformatics
Education and Positions:
Ph.D., Michigan State University
Dr. Jou, Yuh-Shan 's
Publications
Dr. Jou, Yuh-Shan 's Lab
Dr. Jou, Yuh-Shan 's Publications
Journal
87
Book
0
Begin
~ End
Chen KJ, Huang JH, Shih JH, Gu DL, Lee SS, Shen R, Hsu YH, Kung YC, Wu CY, Ho CM, Jen HW, Lee HY, Lang YD, Hsiao CH, Jou YS
Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma..
Molecular carcinogenesis (2023)
[JCR]
[WOS]
Wang YW, Chen SC, Gu DL, Yeh YC, Tsai JJ, Yang KT, Jou YS, Chou TY, Tang TK
A novel HIF1alpha-STIL-FOXM1 axis regulates tumor metastasis..
Journal of biomedical science 29(1), 24 (2022)
[JCR]
[WOS]
Chen HY, Chan SJ, Liu X, Wei AC, Jian RI, Huang KW, Lang YD, Shih JH, Liao CC, Luan CL, Kao YT, Chiang SY, Hsiao PW, Jou YS, Chen Y, Chen RH
Long noncoding RNA Smyca coactivates TGF-beta/Smad and Myc pathways to drive tumor progression..
Journal of hematology & oncology 15(1), 85 (2022)
[JCR]
[WOS]
Ho CM, Lin KT, Shen R, Gu DL, Lee SS, Su WH, Jou YS
Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma..
Computational and structural biotechnology journal 20, 1752-1763 (2022)
[JCR]
[WOS]
Lang YD, Jou YS
PSPC1 is a new contextual determinant of aberrant subcellular translocation of oncogenes in tumor progression..
Journal of biomedical science 28(1), 57 (2021)
[JCR]
[WOS]
Jen Hsin-Wei, Gu De-Leung, Lang Yaw-Dong, Jou Yuh-Shan
PSPC1 Potentiates IGF1R Expression to Augment Cell Adhesion and Motility.
Cells 9(6), 1490 (2020-06)
[JCR]
[WOS]
Shih JH, Chen HY, Lin SC, Yeh YC, Shen R, Lang YD, Wu DC, Chen CY, Chen RH, Chou TY, Jou YS*
Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma..
Nucleic acids research 48(3),1175-1191 (2020-02)
[JCR]
[WOS]
Lang Yaw-Dong, Jou Yuh-Shan
PSPC1: a contextual determinant of tumor progression.
Molecular & Cellular Oncology 7(2), 1721253 (2020-02)
[JCR]
[WOS]
Lang YD, Chen HY, Ho CM, Shih JH, Hsu EC, Shen R, Lee YC, Chen JW, Wu CY, Yeh HW, Chen RH, Jou YS*
PSPC1-interchanged interactions with PTK6 and beta-catenin synergize oncogenic subcellular translocations and tumor progression..
Nature communications 10(1), 5716 (2019-12)
[JCR]
[WOS]
Yeh HW, Lee SS, Chang CY, Lang YD, Jou YS*
A New Switch for TGFbeta in Cancer..
Cancer research 79(15), 3797-3805 (2019-08)
[JCR]
[WOS]
«
1
2
3
»